Actively Recruiting
Using AI-ECG Technology to Detect and Monitor Atrial Fibrillation and Related Heart Rhythms in Adults
Led by National Defense Medical Center, Taiwan · Updated on 2025-11-19
14726
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of an AI-powered ECG alert system called AF-predict to help doctors identify patients at high risk for developing atrial fibrillation AF, atrial flutter AFL, or other atrial arrhythmias. This trial focuses on patients who have premature atrial complexes or other arrhythmias that increase AF risk. The study aims to improve early detection and tracking of these heart rhythm issues by alerting physicians to patients who may benefit from continuous cardiac monitoring. Participants are divided into two groups. In the experimental group, all ECGs are analyzed by the AF-predict AI system patients with at least one high-risk ECG in the past year will be asked to wear a continuous cardiac rhythm monitor for up to 7 days. Physicians can review AI-ECG results to guide care. The control group receives standard care without AI-ECG analysis until the study ends. This randomized trial compares the new AI-based approach to usual care. During the study, researchers will monitor participants for new diagnoses of latent atrial fibrillation within 90 days of enrollment. They will also track antiarrhythmic treatments and other arrhythmia diagnoses during this period and up to 180 days for treatment use. Participants will undergo ECG monitoring and follow-up to assess heart rhythm. The study tracks safety and outcomes to determine if AI alerts improve detection and management of atrial arrhythmias.
CONDITIONS
Brief Title
Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development
Research Team
C
Chin Lin, PhD
C
ChiaoChin Lee, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here